John Patin

Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America.

Michael Wang, Michael L. Wang, S. Lonial, 2007, The New England journal of medicine.

Thalidomide for patients with relapsed multiple myeloma after high-dose chemotherapy and stem cell transplantation: results of an open-label multicenter phase 2 study of efficacy, toxicity, and biological activity.

Faith Davies, Edie Weller, Kenneth Anderson, 2004, Mayo Clinic proceedings.

Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma.

Alessandro Corso, Robin Foà, M. Dimopoulos, 2007, The New England journal of medicine.

Predictors of response to clozapine therapy

John Patin, G. Honigfeld, Gilbert Honigfeld, 2004, Psychopharmacology.